COVID-19 Pnömonisi - Brusella spp. Koenfeksiyonu : Olgu Sunumu

Yıl 2021, Cilt: 4 Sayı: 3, 289 - 292, 01.09.2021

Emine Kübra Dindar Demiray , Hanife Nur Karakoç , Hacer Akşit Erdinç Eren Özgür Paşa Gökhan Şahin , Ömer Duran Fadime Gülpınar Saadet Yıldırım Edip Yıldız Eren Bektaş

https://doi.org/10.19127/bshealthscience.867187

Öz

COVID-19 (SARS-CoV-2) insanlarda orta-şiddetli akut solunum yolu sendromu oluşturan bulaşıcı bir hastalıktır. İlk olarak Çin'in Hubei eyaletinin Wuhan şehrinde keşfedilmiş olan hastalık, dünya çapında yayılarak COVID -19 pandemisine yol açmıştır. COVID-19 tanılı hastaların klinik takibi sırasında hastalıkla beraber diğer enfeksiyon etkenlerine de rastlanmaktadır. Brusellozis çok çeşitli organ tutulumu yapma özelliği nedeniyle farklı klinik tablolarla prezente olabilir. Ender olarak özellikle endemik bölgelerde sepsis sebebi ile izlenen hastalarda altta yatan bir hastalık olarak karşımıza da çıkabilmektedir. Hastalık birçok hastalığı taklit edebildiği için ve klinisyenin gözünden kaçabileceği için tanının gecikmesine neden olabilir. Bu vaka sunumunda; altta yatan kronik obstruktif akciğer hastalığı olan, COVID-19 pandemi sürecinde PCR testi pozitif olarak sonuçlanan hastada saptanan Brusella koenfeksiyonunu vurgulamayı amaçladık.

Anahtar Kelimeler

Bruselloz, Brusella spp, COVID-19 (SARS-CoV-2), Koenfeksiyon, Sepsis

Destekleyen Kurum

bulunmamaktadır

Proje Numarası

bulunmamaktadır

COVID-19 Pneumonia Brusella spp. Coinfection: Case Report

Öz

COVID-19 (SARS-CoV-2) is an infectious disease with moderate to severe acute respiratory syndrome. The disease, which was first discovered in Wuhan, China's Hubei province, has spread worldwide, causing a COVID -19 pandemic. During the clinical follow-up of patients diagnosed with COVID-19, other infectious agents are also encountered. Brucellosis can be presented with different clinical presentations due to its wide variety of organ involvement. Rarely, it may also appear as an underlying disease in patients who are followed up due to sepsis especially in endemic regions. The disease can cause delay in diagnosis, as it can mimic many diseases and escape the clinician's eye. In this case report; we aimed to emphasize the brucellosis coinfection detected in the patient with underlying chronic obstructive pulmonary disease who had a positive PCR test during the COVID-19 pandemic.

Anahtar Kelimeler

Brucellosis, Brusella spp, COVID-19 (SARS-CoV-2), Coinfection, Sepsis

Proje Numarası

bulunmamaktadır

Kaynakça

• Alp E, Doğanay M. 2017. Bruselloz. In: Topçu Wilke A, Söyletir G, Doğanay M. (eds) İnfeksiyon hastalıkları ve mikrobiyolojisi. 4. baskı. Nobel Tıp Kitabevi, İstanbul: s. 863-8637.
• Bulut Y, Cartı Ö, Yıldırım F, Akcan M, Aral, YZ. 2016. Secondary hemophagocytic lymphohistiocytosis in an adolescent case: ıs the brucella or coronavirus the primary cause? J Pediatr Inf 2016; 10: 28-32.
• Çeviker AS, Demiray DE. 2020. A case of acute brucellosis that presenting with cutaneous manifestations. J Biotec Strategic Health Res, 42: 184-187.
• Çeviker AS, Elmaslar MH, Gedi̇k M. 2019. Akut kolesistit ile başvuran atipik bruselloz olgusu. Sakarya Tıp Derg, 9(4): 702-705.
• Elzein F, Alsherbeeni N, Almatrafi K, Shosha D, Naoufel K. 2020. COVID-19 co-infection in a patient with brucella bacteremia. Respiratory Med Case Rep, 31: 101183.
• Gu J, Han B, Wang J. 2020. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology, 158(6): 1518-1519.
• Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 382:1708-1720.
• Gwida M, Al Dahouk S, Melzer F, Rösler U, Neubauer H, Tomaso H. 2010. Brucellosis - regionally emerging zoonotic disease? Croat Med J, 51(4):289-295.
• Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. 2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 91: 264-266.
• Li YC, Bai WZ, Hashikawa T. 2020. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol, 92(6): 552-555.
• Lv Z, Cheng S, Le J, Huang J, Feng L, Zhang B, Li Y. 2020. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study. Microbes Infect, 22(4-5): 195–199.
• Miri SM, Roozbeh F, Omrani A, Alavian SM. 2020. Panic of buying toilet papers: a historical memory or a horrible truth? systematic review of gastrointestinal manifestations of COVID-19. Hepatitis Monthly. In Press (In Press. 10.5812/hepatmon.102729. ISSN 1735-143X.
• Rawson TM, Moore L, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. 2020. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Diseas, 71(9): 2459–2468.
• URL 1. WHO Director-General's opening remarks at the media briefing on COVID-19. World Health Organization (Erişim tarihi: 12 Mart 2020).
• URL 2. Q&A on coronaviruses (COVID-19. World Health Organization (Erişim tarihi: 11 Mart 2020).
• URL 4. Q&A on coronaviruses. World Health Organization (WHO) (Erişim tarihi: 27 Mayıs 2020).
• URL 5. Coronavirus death rate: What are the chances of dying? (Erişim tarihi: 24 Mart 2020).
• URL 6. https://covid19.who.int/ (Erişim tarihi: 19 Nisan 2021).
• URL 7. Covid19.saglik.gov.tr/Eklenti/40719/0/covid-19rehberieriskinhastayonetimivetedavipdf.pdf (Erişim tarihi: 19 Mart 2021).
• Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. 2020. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med, 8(5): 475-481.